Volume and effectiveness assessment of articain 4% versus mepivacaine 2% used in third molar surgery: randomized, double-blind, split-mouth controlled clinical trial.

BACKGROUND: The different indications for extraction of the lower third molars, require resources to manage pain and discomfort, such as, for example, adequate anesthetic techniques, and the type of anesthetic used can influence the management of pain in tooth extractions. Few studies in the literature compare the anesthetics 4% articaine hydrochloride and 2% mepivacaine hydrochloride showing evidence that both allow for successful pain management. This study sought to compare the volume, efficacy and safety of these two anesthetic drugs, both associated with epinephrine at a ratio of 1:100,000, used in the extraction of lower third molars. MATERIAL AND METHODS: A controlled, clinical, split-mouth compared these both local anesthetics in a sample of 20 patients requiring bilateral extraction of teeth. Pain was the main parameter to be assessed by means of the visual analogue scale (VAS) applied during and immediately after the surgery. Hemodynamic parameters, adverse events, presence of paresthesia and satisfaction of patients and surgeon were also analysed. RESULTS: Pain management was more effective with mepivacaine up to two hours after surgery (p=0.014), whereas the surgeon was more satisfied with the use of articaine during divulsion and suture (p<0.05). However no statistically significant differences were found between both anesthetics regarding pain perception. CONCLUSIONS: It was observed that both anesthetics are efficient and safe in the management of pain for extraction of third molars, in which less amount of mepivacaine is needed. The satisfaction of patients and surgeon was the same for both anesthetics, with articaine being highlighted during divulsion and suture.

[Control of hemotherapy and transfusional Chagas disease: 1988 and 1990]. / Controle da hemoterapia e da doença de Chagas transfusional: 1988 e 1990.

An inquiry with the objective of bringing the study of the hemotherapy situation in the state of S. Paulo, up-to-date was undertaken in 1990 and compared with that carried out in 1988. In 1990 research was undertaken in 62 counties, 48 of which performed blood transfusions through 104 services, with hemocenter participation in 13.5% of these latter. In 1988 the respective figures were 57, 40, 71 and 8.5%. The number of donors and transfusions and prevalence of serological positivity for Chagas' disease were, respectively: 105,170; 79,544 and 1.24%, while in 1988 the corresponding numbers were: 51,614; 49,211 and 1.52%. Evaluating the serological selection it was found that the following percentages of the services performed serological tests: for Chagas' disease (94.2%), syphilis (94.2%), hepatitis (94.2%), HIV (92.3%) and malaria (20.2%) while in 1988 only 69.0%; 70.4%; 67.6%, 63.4% and 16.9%, respectively, of the services utilized these same tests. In respect of the serological trial specific for Chagas' disease the results were: complement fixation-4.9%; latex-4.0%; indirect immunofluoresce-80%; direct hemaglutination-24.0%, indirect hemaglutination-69.0% and ELISA-59.0% of all services. In the preceding inquiry only 14.3% of the services performed the ELISA test, and complement fixation was utilized in 28.6%. The results show that the services are utilizing ever more sensitive techniques in the serological routine. Further it was observed that in 1988, 77.6% of all the services studied used only one technique for the diagnosis of Chagas' disease while in 1990 92.9% utilized two or more different techniques. It is concluded that the quality of the hemotherapy undertaken in the state of S. Paulo has improved significantly.

[Hemotherapy and transfusional Chagas' disease in Brazil]. / Hemoterapia e doença de Chagas transfusional no Brasil.

With the increased presence of Chagas' disease in urban areas and the rising importance of transfusional transmission of Trypanosoma cruzi, a proper and realistic approach to hemotherapeutic treatment has become crucial in Brazil. Bringing together data from various institutions, this study analyzed hemotherapy and the problem of transfusional Chagas' disease in 850 Brazilian municipalities from 1988 to 1989. It was found that some type of hemotherapy was practiced in 68.8% of these municipalities at the time, this practice being qualitatively and quantitatively proportional to the population size of the municipality. The official blood bank system supplied the blood used in 13% of these services. In relation to prevention of the main diseases transmissible by transfusion, prior screening of donors was carried out by 75.2% of the services for syphilis, 65.4% for hepatitis, 53.8% for AIDS, and 66.9% for Chagas' disease. These percentages vary by region and by size of the municipality. The majority of donors are classified as voluntary, with only 2% categorized as paid donors. In the case of Chagas' disease, most services used only one serologic technique to screen donors, most commonly hemagglutination or immunofluorescence, while only 10.3% of services had previous experience with chemoprophylaxis using gentian violet. The proportion of potential donors with positive serology for anti-Trypanosoma cruzi antibodies was around 1%. These data were confirmed by information from blood banks and Brazilian hemotherapy professionals.